 | Info Sheets |
| | | | | | | | | | | | | | | | | | | | | | | | |
 | Out- side |
| | | | |
|
| | | | MRI News Service: 'Magnetic Resonance Angiography MRA' | | |
|  |  | | | '''''With recent improvement in hardware and software techniques, magnetic resonance angiography (MRA) has undergone significant changes in technique and approach. The advent of 3.0 T magnets has allowed reduction in exogenous contrast dose without ...' | | Wednesday, 9 March 2011 by www.jcmr-online.com |
|
|  |  | | | '''''Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic medical imaging, today announced the Canadian launch of ABLAVAR® (gadofosveset trisodium injection), a unique, injectable magnetic resonance angiography (MRA) blood pool imaging agent. ...' | | | Thursday, 14 October 2010 by www.radiopharm.com | |
|
|  |  | | | ''''' Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic medical imaging, today announced that it has acquired the balance of the worldwide rights for gadofosveset trisodium, a unique, injectable magnetic resonance angiography (MRA) blood pool ...' | | | Monday, 12 July 2010 by www.radiopharm.com | |
|
|  |  | | | '''''Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic medical imaging, today announced the first national contract signed for ABLAVAR® with Amerinet, Inc., a leading national healthcare group purchasing organization. ABLAVAR® (gadofosveset ...' | | | Thursday, 3 June 2010 by www.businesswire.com | |
|
|  |  | | | '''''Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic imaging, today announced the launch of ABLAVARâ„¢ (gadofosveset trisodium), a unique, injectable MRA imaging agent used to evaluate aortoiliac occlusive disease (AIOD) in adults with known ...' | | | Wednesday, 20 January 2010 by www.radiopharm.com | |
|
|  |  | | | '''''Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic imaging, today announced that two oral presentations featuring gadofosveset trisodium, the first and only FDA approved blood pool contrast agent for magnetic resonance angiography (MRA), ...' | | | Thursday, 8 October 2009 by www.businesswire.com | |
|
|  |  | | | '''''WASHINGTON, Dec. 24 (Xinhua) -- The U.S. Food and Drug Administration on Wednesday approved Vasovist Injection, the first contrast imaging agent for use in patients undergoing magnetic resonance angiography, or MRA, a minimally invasive test for ...' | | | Thursday, 25 December 2008 by news.xinhuanet.com | |
|
|  |  | |  | |  | Result Pages | |  |
|
 |
You can fool some of the people all of the time, and all of the people some
of the time, but you can not fool all of the people all of the time. -
Abraham Lincoln |
 |
|
|
| |
 | Look Ups |
| |